MedTrace Logo

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

NCT03465462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2018-03-14

No results posted yet for this study

Summary

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical parameters of newly diagnosed hypertensive patients on monotherapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

group/arm C (control group)

Group C in the third stage (30 days) continued drug use with no change in diet and no mineral supplementation.

DIETARY_SUPPLEMENT

group/arm D (diet group)

Group D in the third stage (30 days) received an optimal-mineral-content properly balanced diet enriched in food with high zinc content.

DIETARY_SUPPLEMENT

group/arm S (supplementation group)

Group S in the third stage (30 days) received zinc supplementation as one capsule containing 15 mg of Zn taken orally once a day in the morning, two hours after antihypertensive drug administration with no change in diet.

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    collaborator OTHER

  • Poznan University of Life Sciences

    lead OTHER

Principal Investigators

  • Joanna Suliburska, Assoc. Prof. · Poznan University of Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2016-12-29
Completion
2016-12-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03465462 on ClinicalTrials.gov